Hybrid approach: a prospective option for treating congenital heart defects in pediatric patients
Frontiers in Cardiovascular Medicine · 16.12.2025 · 12
DOI: 10.3389/fcvm.2025.1711494 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 16.12.2025. Verfasst von Shukhrat Marassulov und 12 weiteren Autor:innen. Beteiligte Einrichtung: JSC National Scientific Medical Center, Astana, Kazakhstan. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 257 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Congenital heart defects (CHDs), a life-threatening congenital pathology, are reported in approximately one out of every 100 live births, with the severity ranging from mild to fatal. The prevalence of CHDs has significantly increased over the last few decades, most likely due to evolved diagnostics and increased accessibility to healthcare worldwide. The ratio of severe CHDs, which require urgent surgery, to mild forms, which may not require surgery, is between 1:4 and 1:3. Therefore, every fourth or fifth newborn with a CHD needs immediate and effective surgical treatment. Furthermore, one in 10 diagnoses involves multiple CHDs, which require complex surgical treatment and elevate the risk of peri- and post-operative mortality. In this review, we focus on ventricular septal defects (VSDs) that constitute a significant proportion of CHDs. We briefly discuss the historical background and current strategies for VSD treatment, including open-heart surgery, transcatheter surgery, and mini-invasive hybrid surgery. The hybrid method is then comprehensively discussed, considering its success and complication rates compared to the other two approaches, its implementation, typical delivery approaches, and the most common types of occluders; we accompany this discussion with our own clinical experiences. The advantages and limitations of the hybrid approach are also discussed. We conclude that the prospects for wider use of the hybrid approach for VSD correction are favorable due to its mini-invasiveness, high safety and effectiveness, and because cardiopulmonary bypass is not needed in this approach.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- JSC National Scientific Medical Center, Astana, Kazakhstan.
Zitieren
APA
Marassulov, S., Lookin, O., Nurkeyev, B., Kerimkulov, A., Murzabayeva, S., Tuyakbayev, B., Dochshanova, R., Maiorov, R., Akhmoldayeva, A., Kuandykova, E., Aldabergenov, Y., Raimkhanov, T., & Adilbekova, A. (2025). Hybrid approach: a prospective option for treating congenital heart defects in pediatric patients. Frontiers in Cardiovascular Medicine, 12. https://doi.org/10.3389/fcvm.2025.1711494
Vancouver
Marassulov S, Lookin O, Nurkeyev B, Kerimkulov A, Murzabayeva S, Tuyakbayev B, et al. Hybrid approach: a prospective option for treating congenital heart defects in pediatric patients. Frontiers in Cardiovascular Medicine. 2025;12. doi:10.3389/fcvm.2025.1711494
BibTeX
@article{Marassulov2025,
author = {Marassulov, Shukhrat and Lookin, Oleg and Nurkeyev, Bakhytzhan and Kerimkulov, Amangeldy and Murzabayeva, Saniya and Tuyakbayev, Bauyrzhan and Dochshanova, Raikhan and Maiorov, Rinat and Akhmoldayeva, Assiya and Kuandykova, Elmira and Aldabergenov, Yerbol and Raimkhanov, Timur and Adilbekova, Akkerbez},
title = {Hybrid approach: a prospective option for treating congenital heart defects in pediatric patients},
journal = {Frontiers in Cardiovascular Medicine},
year = {2025},
volume = {12},
doi = {10.3389/fcvm.2025.1711494}
}
EUVIMED